OPK - OPKO Health, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
2.5300
-0.1900 (-6.99%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close2.7200
Open2.6400
Bid2.4500 x 900
Ask2.5200 x 3100
Day's Range2.5200 - 2.7250
52 Week Range2.3400 - 6.4000
Volume4,644,062
Avg. Volume5,851,793
Market Cap1.557B
Beta (3Y Monthly)1.68
PE Ratio (TTM)N/A
EPS (TTM)-0.2720
Earnings DateMay 6, 2019 - May 10, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.33
Trade prices are not sourced from all markets
  • GlobeNewswire4 days ago

    OPKO Announces Positive Topline Results In Phase 2 Diabetes And Obesity Trial

    MIAMI, March 21, 2019 -- OPKO Health, Inc. (NASDAQ: OPK) today announced positive topline results from a Phase 2 dose escalation trial of OPK88003 to treat type 2 diabetes and.

  • Thomson Reuters StreetEvents19 days ago

    Edited Transcript of OPK earnings conference call or presentation 27-Feb-19 9:30pm GMT

    Q4 2018 OPKO Health Inc Earnings Call

  • OPKO Health (OPK) Reports Loss in Q4, Misses on Revenues
    Zacks21 days ago

    OPKO Health (OPK) Reports Loss in Q4, Misses on Revenues

    OPKO Health (OPK) witnesses sluggishness in the Products revenues segment in Q4. However, contribution from RAYALDEE has been significant in the quarter.

  • GuruFocus.com23 days ago

    OPKO Health Inc (OPK) Files 10-K for the Fiscal Year Ended on December 31, 2018

    OPKO Health Inc (NASDAQ:OPK) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018.

  • Who OPKO Health Is Tanking Today
    Motley Fool25 days ago

    Who OPKO Health Is Tanking Today

    Traders didn't like the company's fourth-quarter results. Should you?

  • ACCESSWIRE25 days ago

    Watch These Four Healthcare Stocks Set The Pace on Thursday

    Premier Health Group (OTC:PHGRF) (CSE:PHGI), Aceto Corporation (ACET), OPKO Health Inc (OPK), and Midatech Pharma plc (NASDAQ:MTP) represent 4 healthcare stocks to pay attention to on Thursday. Premier Health Group (OTC:PHGRF) (CSE:PHGI) is a company which is laser-focused on developing innovative approaches that combine human skill-based expertise with state-of-the-art technologies to champion products and services meant to improve the quality of life for consumers. Premier Health Group (OTC:PHGRF) (CSE:PHGI) today announced the launch of at technology-enabled mental health counseling service for patients in urban centers and remote and underserved populations.

  • Opko Health Inc (OPK) Q4 2018 Earnings Conference Call Transcript
    Motley Fool25 days ago

    Opko Health Inc (OPK) Q4 2018 Earnings Conference Call Transcript

    OPK earnings call for the period ending December 31, 2018.

  • GlobeNewswire26 days ago

    OPKO Health Reports 2018 Fourth Quarter Business Highlights and Financial Results

    MIAMI, Feb. 27, 2019 -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended December 31, 2018. Business.

  • GlobeNewswire27 days ago

    OPKO Health to Announce Fourth Quarter 2018 Financial Results on February 27, 2019

    OPKO Health, Inc. (OPK) plans to announce its operating and financial results for the three and twelve months ended December 31, 2018 as well as provide guidance on expected revenues and operating expenses for the first quarter 2019 after the close of the U.S. financial markets on Wednesday, February 27, 2019. OPKO’s senior management will provide a business update and discuss its financial results in a live conference call and audio webcast beginning at 4:30 p.m. Eastern time on Wednesday, February 27, 2019. OPKO’s senior management will provide a business update and discuss results in greater detail in a conference call and live audio webcast at 4:30 p.m. Eastern time on Wednesday, February 27, 2019.

  • GlobeNewswirelast month

    Research Report Identifies Cognizant Technology Solutions, OPKO Health, MedEquities Realty Trust, AXT, Red Robin Gourmet Burgers, and Dorian LPG with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

    NEW YORK, Feb. 13, 2019 -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders,.

  • Markitlast month

    See what the IHS Markit Score report has to say about OPKO Health Inc.

    OPKO Health Inc NASDAQ/NGS:OPKView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is moderate and declining * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is moderate for OPK with between 5 and 10% of shares outstanding currently on loan. However, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on February 6. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding OPK totaled $7.59 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Why Glu Mobile, Opko Health, and Church & Dwight Slumped Today
    Motley Fool2 months ago

    Why Glu Mobile, Opko Health, and Church & Dwight Slumped Today

    Despite a solid upward move for the stock market, these three lagged behind.

  • Why Opko Health Is Tanking Today
    Motley Fool2 months ago

    Why Opko Health Is Tanking Today

    A convertible senior note offering and related issuing of new shares caused the healthcare stock to plunge.

  • GlobeNewswire2 months ago

    OPKO Health, Inc. Announces the Pricing of its Offering of Convertible Senior Notes

    OPKO Health, Inc. (“OPKO Health” or the “Company”) (OPK) today announced the pricing of its offering of $200 million aggregate principal amount of Convertible Senior Notes due 2025 (the “Notes”). The Notes will be general senior unsecured obligations of the Company, will pay interest semiannually in arrears at a rate of 4.50% per annum, and will mature on February 15, 2025, unless earlier repurchased, redeemed or converted. The Notes will be convertible into, at the Company’s election, cash, shares of the Company’s common stock, or a combination of cash and common stock, as further described in the prospectus supplement.

  • Benzinga2 months ago

    The Daily Biotech Pulse: Gilead Earnings, Codexis Sings Pact With Merck, Eli Lilly Reports Positive Trial Results

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Feb. 4) AEterna Zentaris Inc. (NASDAQ: AEZS ) Axsome Therapeutics ...

  • PR Newswire2 months ago

    Johnson Fistel, LLP Announces Investigations of AbbVie Inc., Macquarie Infrastructure Corporation, OPKO Health, Inc. and Uxin Limited; Investors Encouraged to Contact Firm

    SAN DIEGO , Feb. 5, 2019 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP is investigating potential claims against the following companies: AbbVie Inc. (NYSE: ABBV) [click here to join ...

  • GlobeNewswire2 months ago

    OPKO Health, Inc. Announces Proposed Offering of Convertible Senior Notes

    OPKO Health, Inc. (“OPKO Health” or the “Company”) (OPK) today announced that, subject to market and other conditions, it intends to offer $200 million aggregate principal amount of Convertible Senior Notes due 2025 (the “Notes”) in an underwritten public offering. The Notes will be general senior unsecured obligations of the Company, will pay interest semiannually in arrears and will be convertible into, at the Company’s election, cash, shares of the Company’s common stock, or a combination of cash and common stock, as further described in the prospectus supplement.

  • Opko gets FDA OK for fingerstick test, seeks reversal on non-coverage ruling
    American City Business Journals2 months ago

    Opko gets FDA OK for fingerstick test, seeks reversal on non-coverage ruling

    The medical test and medication company is betting on the future of its 4Kscore diagnostic test, but has hit a roadblock.

  • GlobeNewswire2 months ago

    OPKO Health Receives FDA Approval for the Point-of-Care Sangia PSA Test with the Claros® 1 Analyzer

    MIAMI, Feb. 01, 2019 -- OPKO Health, Inc. (NASDAQ: OPK) today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s point-of-care Sangia Total.

  • GlobeNewswire2 months ago

    OPKO Provides Update on the Development of OPK-88004, a Selective Androgen Receptor Modulator

    OPKO Health, Inc. (OPK) today announced an update on the ongoing development plans of OPK-88004, a selective androgen receptor modulator (SARM). OPK-88004 has the ability to serve as an antagonist to androgen receptors in the prostate, resulting in decreased prostate specific antigen (PSA) levels, and as an agonist resulting in increased anabolic effects, such as increased lean body mass and physical function and decreased fat mass.

  • GlobeNewswire2 months ago

    Future Non-Coverage Determination for 4Kscore Test Posted by Novitas

    OPKO Health, Inc. (OPK) today announced that Novitas Solutions, Inc. has issued a notice of a future non-coverage determination for the 4Kscore test® to be effective March 20, 2019. The notice released by Novitas today does not appear to be different from the draft local coverage determination released by Novitas on May 18, 2018. OPKO is evaluating options to appeal the decision and undertake other steps with the U.S. Centers for Medicare & Medicaid Services (CMS) in an effort to have this determination rescinded or reversed.

  • ACCESSWIRE2 months ago

    Today's Research Reports on Trending Tickers: OPKO Health and Endo International

    NEW YORK, NY / ACCESSWIRE / January 28, 2019 / U.S. equities closed higher on Friday as companies continue to report upbeat earnings and Trump and the Democrats agreed to reopen the government until Feb. ...

  • GlobeNewswire2 months ago

    BioReference Laboratories Supports Federal Employees Amidst Government Shutdown

    BioReference Laboratories Inc., an OPKO Health Company (OPK), today announced that they will offer flexible payment arrangements for federal employees affected by the government shutdown. “We recognize the challenging financial position that federal government employees have faced throughout the shutdown,” said Jon R. Cohen, M.D., Executive Chairman of BioReference Laboratories. BioReference and its divisions, GenPath Diagnostics and GeneDx, developed a program to defer laboratory payments for 30 days to furloughed federal government employees.